TY - JOUR
T1 - Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis
AU - De Pascale, Gennaro
AU - Antonelli, Massimo
AU - Deschepper, Mieke
AU - Arvaniti, Kostoula
AU - Blot, Koen
AU - Brown, Ben Creagh
AU - de Lange, Dylan
AU - De Waele, Jan
AU - Dikmen, Yalim
AU - Dimopoulos, George
AU - Eckmann, Christian
AU - Francois, Guy
AU - Girardis, Massimo
AU - Koulenti, Despoina
AU - Labeau, Sonia
AU - Lipman, Jeffrey
AU - Lipovetsky, Fernando
AU - Maseda, Emilio
AU - Montravers, Philippe
AU - Mikstacki, Adam
AU - Paiva, José-Artur
AU - Pereyra, Cecilia
AU - Rello, Jordi
AU - Timsit, Jean-Francois
AU - Vogelaers, Dirk
AU - Blot, Stijn
N1 - Funding Information:
AbSeS is a Trials Group Study of the European Society of Intensive Care Medicine. The study was supported by a Pfizer investigator-initiated research grant.
Publisher Copyright:
© 2022, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/11
Y1 - 2022/11
N2 - Purpose: To describe data on epidemiology, microbiology, clinical characteristics and outcome of adult patients admitted in the intensive care unit (ICU) with secondary peritonitis, with special emphasis on antimicrobial therapy and source control. Methods: Post hoc analysis of a multicenter observational study (Abdominal Sepsis Study, AbSeS) including 2621 adult ICU patients with intra‐abdominal infection in 306 ICUs from 42 countries. Time-till-source control intervention was calculated as from time of diagnosis and classified into ‘emergency’ (< 2 h), ‘urgent’ (2–6 h), and ‘delayed’ (> 6 h). Relationships were assessed by logistic regression analysis and reported as odds ratios (OR) and 95% confidence interval (CI). Results: The cohort included 1077 cases of microbiologically confirmed secondary peritonitis. Mortality was 29.7%. The rate of appropriate empiric therapy showed no difference between survivors and non-survivors (66.4% vs. 61.3%, p = 0.1). A stepwise increase in mortality was observed with increasing Sequential Organ Failure Assessment (SOFA) scores (19.6% for a value ≤ 4–55.4% for a value > 12, p < 0.001). The highest odds of death were associated with septic shock (OR 3.08 [1.42–7.00]), late-onset hospital-acquired peritonitis (OR 1.71 [1.16–2.52]) and failed source control evidenced by persistent inflammation at day 7 (OR 5.71 [3.99–8.18]). Compared with ‘emergency’ source control intervention (< 2 h of diagnosis), ‘urgent’ source control was the only modifiable covariate associated with lower odds of mortality (OR 0.50 [0.34–0.73]). Conclusion: ‘Urgent’ and successful source control was associated with improved odds of survival. Appropriateness of empirical antimicrobial treatment did not significantly affect survival suggesting that source control is more determinative for outcome.
AB - Purpose: To describe data on epidemiology, microbiology, clinical characteristics and outcome of adult patients admitted in the intensive care unit (ICU) with secondary peritonitis, with special emphasis on antimicrobial therapy and source control. Methods: Post hoc analysis of a multicenter observational study (Abdominal Sepsis Study, AbSeS) including 2621 adult ICU patients with intra‐abdominal infection in 306 ICUs from 42 countries. Time-till-source control intervention was calculated as from time of diagnosis and classified into ‘emergency’ (< 2 h), ‘urgent’ (2–6 h), and ‘delayed’ (> 6 h). Relationships were assessed by logistic regression analysis and reported as odds ratios (OR) and 95% confidence interval (CI). Results: The cohort included 1077 cases of microbiologically confirmed secondary peritonitis. Mortality was 29.7%. The rate of appropriate empiric therapy showed no difference between survivors and non-survivors (66.4% vs. 61.3%, p = 0.1). A stepwise increase in mortality was observed with increasing Sequential Organ Failure Assessment (SOFA) scores (19.6% for a value ≤ 4–55.4% for a value > 12, p < 0.001). The highest odds of death were associated with septic shock (OR 3.08 [1.42–7.00]), late-onset hospital-acquired peritonitis (OR 1.71 [1.16–2.52]) and failed source control evidenced by persistent inflammation at day 7 (OR 5.71 [3.99–8.18]). Compared with ‘emergency’ source control intervention (< 2 h of diagnosis), ‘urgent’ source control was the only modifiable covariate associated with lower odds of mortality (OR 0.50 [0.34–0.73]). Conclusion: ‘Urgent’ and successful source control was associated with improved odds of survival. Appropriateness of empirical antimicrobial treatment did not significantly affect survival suggesting that source control is more determinative for outcome.
KW - Antimicrobial therapy
KW - Intra-abdominal infection
KW - Mortality
KW - Secondary peritonitis
KW - Source control
UR - http://www.scopus.com/inward/record.url?scp=85140368936&partnerID=8YFLogxK
U2 - 10.1007/s00134-022-06883-y
DO - 10.1007/s00134-022-06883-y
M3 - Article
C2 - 36151335
SN - 0342-4642
VL - 48
SP - 1593
EP - 1606
JO - Intensive Care Medicine
JF - Intensive Care Medicine
IS - 11
ER -